Clinical Trials in Ha’erbin, China
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Colorectal, CancerHead and Neck CancerNon-small Cell Lung Cancer+1 more
Betta Pharmaceuticals Co., Ltd.400 enrolled87 locationsNCT04930432
Recruiting
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd400 enrolled87 locationsNCT06079983
Recruiting
Phase 2
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients with Recurrent or Metastatic Cervical Cancer
Adult
Grit Biotechnology83 enrolled24 locationsNCT06241781
Recruiting
Phase 2
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Abbisko Therapeutics Co, Ltd82 enrolled5 locationsNCT06111274
Recruiting
Phase 2
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
AML, Adult
Shanghai Tong Ren Hospital58 enrolled19 locationsNCT05736965